Products
Investing
Resources
Support
GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
₹2,902.2
INR+55.60(+1.95%)
As of April 29, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹50400.64 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹45382.57 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
56.35
Forward P/E
Price to Earnings ratio based on forecasted earnings
49.37
PEG Ratio
Price/Earnings to Growth ratio
49.37
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
13.60
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
62.17%
Operating Margin
Operating income as a percentage of revenue
28.77%
Return on Equity
Net income as a percentage of shareholders' equity
33.19%
Revenue (TTM)
Total revenue over trailing 12 months
₹3704.64 Cr+17.9%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1186.85 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹50.73+402.79999999999995%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2110.83 Cr
Total Debt
Total short-term and long-term debt
₹14.79 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
0.88%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1921 - ₹3148
Beta
Measure of stock's volatility compared to the market
0.13
Shares Outstanding
Total number of shares issued by the company
₹16.94 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.64%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.41%
Payout Ratio
Percentage of earnings paid as dividends
63.09%